Get In Touch
  • According to Transparency Market Research’s latest report on the global hemostasis and tissue sealing agents market for the historical period 2017–2018 and forecast period 2019–2027, rise in demand for minimally invasive procedures and increase in global geriatric population are projected to drive the global hemostasis and tissue sealing agents market during the forecast period
  • According to the report, the global hemostasis and tissue sealing agents market was valued at US$ 5.1 Bn in 2018 and is anticipated to expand at a CAGR of 8.3% from 2019 to 2027

Request a sample to get extensive insights into the Automotive Heat Shield Market

Rise in demand for minimally invasive procedures: Key Drivers

  • The preference for minimally invasive surgeries has increased significantly in the past few years. Minimally invasive surgeries have advantages such as shorter hospital stay, minimal incision, fewer post-surgical complications and shorter recovery time. Systemic hemostatic agents such as gelatin and collagen-based hemostat powders are widely used in minimally invasive procedures. These agents enable surgeons to perform complex surgeries.
  • According to a study conducted by the World Health Organization (WHO), approximately 234.2 million major surgical procedures are undertaken by various hospitals and surgical centers across the world each year. Thus, rising number of surgical procedures and growing preference for minimally invasive procedures boosts the demand of hemostat and tissue sealing agents.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Aging population increases the number of surgeries needing hemostat products boost market growth

  • Treatment services have become affordable due to improvement in health care policies in countries such as the U.S., Japan, the U.K. and China. This, in turn, has increased the life expectancy of the population. Consequently, rise in the geriatric population increases the number of surgical procedures that use adhesion barrier and hemostat products. According to the U.S. Department of Health & Human Product estimates, the U.S. will have about 72.1 Mn geriatric population by 2030, which is more than twice the number in 2000.
  • The UN Population Division has projected that the number of people aged 60 years and above will increase significantly during 2015–2030. In developed countries, the total proportion of people aged 60 years and above has increased from 12% in 1950 to 22% in 2011 and is expected to reach 32% by 2050. Thus, the aging population drives the uptake of hemostat, tissue sealant and adhesion barrier products and boosts market growth.

High cost and strict regulatory requirement to Hamper Market

  • Hemostat and tissue sealant products development is a complex and expensive process. Regulatory approval of hemostat products demands valid scientific evidences, well controlled investigations and documented case studies. Despite high expense incurred for the development of hemostat products by manufacturers, the success rate of the approval of these products by regulatory bodies is low. Low efficacy and safety of the products have been attributed to the low approval rate of hemostat products. Only a small number of companies have entered the market due to setbacks faced in clinical studies by hemostat manufacturers. This hampers the growth of the hemostasis and tissue sealing agents market.

Global Hemostasis and tissue sealing agents Market: Competitive Landscape

  • This report profiles major players in the global hemostasis and tissue sealing agents market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global Hemostasis and tissue sealing agents market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global Hemostasis and tissue sealing agents market are
    • Advanced Medical Solutions Group plc
    • Baxter
    • Cohera Medical, Inc.
    • CryoLife, Inc.
    • C.R. Bard, Inc.
    • Johnson & Johnson Services, Inc.
    • Integra LifeSciences Corporation
    • Pfizer, Inc.
    • Cohesion Technologies Inc.
    • B Braun Medical Inc
    • other prominent players.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Hemostasis and Tissue Sealing Agents Market

Global Hemostasis and Tissue Sealing Agents Market: Key Developments

Key players in the global hemostasis and tissue sealing agents market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global hemostasis and tissue sealing agents market. A few expansion strategies adopted by players operating in the global Hemostasis and tissue sealing agents market are:

  • In July 2020, Sysmex Corporation launched new product in the hemostasis field i.e. Automated Blood Coagulation Analyzers, which is used for chemiluminescence enzyme immunoassay to enhance testing workflow efficiency
  • In January 26, 2020, Terumo Corporation launched new surgical sealant product i.e. AQUABRID in EMEA Market. This product helps to stop bleeding during aortic surgical procedures.
  • In January 2018, Baxter acquired two hemostat and sealant products i.e. RECOTHROM and PREVELEAK from Mallinckrodt plc for broaden portfolio of innovative surgical products.

The report on the global hemostasis and tissue sealing agents market discussed individual strategies, followed by company profiles of manufacturers of hemostasis and tissue sealing agents. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global hemostasis and tissue sealing agents market.

Global Hemostasis and Tissue Sealing Agents Market - Scope of Report

TMR’s report on the global hemostasis and tissue sealing agents market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global hemostasis and tissue sealing agents market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global hemostasis and tissue sealing agents market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global hemostasis and tissue sealing agents market.

Secondary research also included internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global hemostasis and tissue sealing agents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global hemostasis and tissue sealing agents market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global hemostasis and tissue sealing agents market.

The report delves into the competitive landscape of the global hemostasis and tissue sealing agents market. Key players operating in the global hemostasis and tissue sealing agents market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global hemostasis and tissue sealing agents market that have been profiled in this report.

Key Questions Answered in Global Hemostasis and Tissue Sealing Agents Market Report

  • What is the scope of growth of product companies in the global hemostasis and tissue sealing agents market?
  • What will be the Y-o-Y growth of the global hemostasis and tissue sealing agents market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global hemostasis and tissue sealing agents market?
  • Will North America continue to be the most profitable market for hemostasis and tissue sealing agents providers?
  • Which factors are anticipated to hamper the growth of the global hemostasis and tissue sealing agents market during the forecast period?
  • Which are the leading companies in the global hemostasis and tissue sealing agents market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global hemostasis and tissue sealing agents market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global hemostasis and tissue sealing agents Market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the hemostasis and tissue sealing agents market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the hemostasis and tissue sealing agents market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global hemostasis and tissue sealing agents market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global hemostasis and tissue sealing agents market more reliably and accurately.

Regional Segmentation of Hemostasis and Tissue Sealing Agents Market

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Global Hemostasis and Tissue Sealing Agents Market – Segmentation

Type

  • Topical Hemostat
    • Mechanical Hemostats
    • Active Hemostats
    • Flowable Hemostats
  • Adhesive and Tissue Sealing Agents
    • Natural Tissue Sealant
    • Synthetic Tissue Sealant
    • Adhesion Barrier Products

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Hemostasis Tissue Sealing Agents Market

Buy Now